|
ZNF121 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.07969999607604E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.57029952877019E-10 |
| Normal-vs-Stage2 |
9.417500E-04 |
| Normal-vs-Stage3 |
2.558000E-03 |
| Normal-vs-Stage4 |
1.278260E-02 |
| Stage1-vs-Stage2 |
9.850000E-01 |
| Stage1-vs-Stage3 |
4.049800E-02 |
| Stage1-vs-Stage4 |
2.471400E-01 |
| Stage2-vs-Stage3 |
1.769210E-01 |
| Stage2-vs-Stage4 |
3.935400E-01 |
| Stage3-vs-Stage4 |
7.666400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.44290002168646E-09 |
| Normal-vs-AfricanAmerican |
2.723800E-02 |
| Normal-vs-Asian |
2.012000E-02 |
| Caucasian-vs-AfricanAmerican |
6.009600E-02 |
| Caucasian-vs-Asian |
1.073580E-01 |
| AfricanAmerican-vs-Asian |
7.395500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.04380000004656E-06 |
| Normal-vs-Female |
1.20380039270174E-10 |
| Male-vs-Female |
4.220500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.474600E-01 |
| Normal-vs-Age(41-60Yrs) |
5.6683999716256E-09 |
| Normal-vs-Age(61-80Yrs) |
9.80649999982042E-07 |
| Normal-vs-Age(81-100Yrs) |
1.162790E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.972600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.747800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.729200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.261000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.467800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.999400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.379400E-03 |
| Normal-vs-Grade 2 |
1.57060031646949E-10 |
| Normal-vs-Grade 3 |
3.54519999999914E-05 |
| Normal-vs-Grade 4 |
7.039700E-02 |
| Grade 1-vs-Grade 2 |
3.972000E-01 |
| Grade 1-vs-Grade 3 |
1.066970E-01 |
| Grade 1-vs-Grade 4 |
1.014750E-01 |
| Grade 2-vs-Grade 3 |
3.663700E-02 |
| Grade 2-vs-Grade 4 |
2.580500E-02 |
| Grade 3-vs-Grade 4 |
4.193000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.72184488889116E-12 |
| Normal-vs-ccB subtype |
2.042900E-04 |
| ccA subtype-vs-ccB subtype |
4.037000E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.1778999693729E-09 |
| Normal-vs-N1 |
4.275600E-01 |
| N0-vs-N1 |
2.642400E-01 |
|
|
